Gemina Laboratories Ltd. (GLAB.CN)
CAD 0.58
(-8.0%)
CAD 0.58
(-8.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -3.24 Million | -4.5 Million | -3.87 Million | -319.09 Thousand |
| Net Income | -5.21 Million | -5.97 Million | -4.73 Million | -834.15 Thousand |
| Depreciation & Amortization | 93.36 Thousand | 50.28 Thousand | 43.83 Thousand | 12.09 Thousand |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 565.01 Thousand | 392.95 Thousand | 702.32 Thousand | - |
| Change in working capital | 1.26 Million | 1.01 Million | 112.92 Thousand | 139.61 Thousand |
| Other non-cash items | 455.22 Thousand | 10.34 Thousand | 4105.00 | 391.47 Thousand |
| Investing Cash Flow | -41.35 Thousand | -505.06 Thousand | 8197.00 | 13.91 Thousand |
| Investments in PPE | -41.35 Thousand | -79.61 Thousand | -9803.00 | - |
| Acquisitions | - | - | - | 33.16 Thousand |
| Investment purchases | - | -429.2 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | 3750.00 | 18 Thousand | -19.25 Thousand |
| Financing Cash Flow | 3.2 Million | 3.94 Million | 4.13 Million | 2.72 Million |
| Debt repayment | -109.53 Thousand | -63.46 Thousand | -67.72 Thousand | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 3.09 Million | 4.29 Million | 2.41 Million | 2.72 Million |
| Other Financing Activities | 200 Thousand | -292.93 Thousand | 1.78 Million | 1582.83 |
| Accounts receivables | 347.22 Thousand | -201.09 | -173.94 | -3937.00 |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | 916.8 Thousand | 1.01 Million | 113.09 Thousand | 143.55 Thousand |
| Cash at beginning of period | 83.09 Thousand | 1.15 Million | 881.94 Thousand | 2.41 Million |
| Cash at end of period | 990.00 | 83.09 Thousand | 1.15 Million | 2.41 Million |
| Capital Expenditure | -41.35 Thousand | -79.61 Thousand | -9803.00 | - |
| Effect of forex changes on cash | - | 1.07 Million | - | -2.41 Million |
| Net cash flow / Change in cash | -82.1 Thousand | -1.07 Million | 274.44 Thousand | 1176.00 |
| Free Cash Flow | -3.28 Million | -4.58 Million | -3.88 Million | -319.09 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -968.61 Thousand | -825.23 Thousand | -5.21 Million | -761.67 Thousand | -1.16 Million | -1.57 Million |
| Depreciation & Amortization | 26.8 Thousand | 26.8 Thousand | 93.36 Thousand | 26.6 Thousand | 27.41 Thousand | 20.64 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 102.69 Thousand | 84.41 Thousand | 565.01 Thousand | 97.67 Thousand | 105.21 Thousand | 183.34 Thousand |
| Change in working capital | 493.98 Thousand | -114.12 Thousand | 1.26 Million | 914.05 Thousand | 457.27 Thousand | 451.33 Thousand |
| Other non-cash items | 60.56 Thousand | 162.29 Thousand | 455.22 Thousand | -272.71 Thousand | 305.15 Thousand | 7358.00 |
| Investing Cash Flow | - | - | -41.35 Thousand | 16.25 Thousand | -12.05 Thousand | -11.46 Thousand |
| Investments in PPE | -2.00 | - | -41.35 Thousand | 16.25 Thousand | -12.05 Thousand | -11.46 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 489.73 Thousand | 805.18 Thousand | 3.2 Million | -26.42 Thousand | 172.96 Thousand | -20.2 Thousand |
| Debt repayment | -27.03 Thousand | -832.84 Thousand | -109.53 Thousand | -26.42 Thousand | -27.03 Thousand | -20.2 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 516.77 Thousand | - | 3.09 Million | - | - | - |
| Other Financing Activities | -1.00 | -27.15 Thousand | 200 Thousand | - | 200 Thousand | 1528.20 |
| Accounts receivables | 6.58 | -636.00 | 347.22 Thousand | 155.19 Thousand | 30.26 Thousand | 80.89 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -77.64 | -113.49 Thousand | 916.8 Thousand | 758.86 Thousand | 427.01 Thousand | 451.25 Thousand |
| Cash at beginning of period | 1665.00 | 990.00 | 83.09 Thousand | 2897.00 | 115.05 Thousand | 1.06 Million |
| Cash at end of period | 206.84 Thousand | 1665.00 | 990.00 | 990.00 | 2897.00 | 115.05 Thousand |
| Capital Expenditure | -2.00 | - | -41.35 Thousand | 16.25 Thousand | -12.05 Thousand | -11.46 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 205.18 Thousand | 675.00 | -82.1 Thousand | -1907.00 | -112.15 Thousand | -947.12 Thousand |
| Free Cash Flow | -284.56 Thousand | -804.51 Thousand | -3.28 Million | 24.51 Thousand | -285.12 Thousand | -926.91 Thousand |
JTC
KRKNP
WLLBW
CARD
ALLSEC
ORAAF